MRSA

>

Latest News

Exebacase Combined With Antibiotics Fails to Improve MRSA Bacteremia Outcomes
Exebacase Combined With Antibiotics Fails to Improve MRSA Bacteremia Outcomes

February 8th 2024

Phase 3 study reveals exebacase combined with standard antibiotics in treating methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis did not meet its primary endpoints.

Evaluating the Efficacy of Daptomycin and Ceftaroline for the Treatment of MRSAB
Evaluating the Efficacy of Daptomycin and Ceftaroline for the Treatment of MRSAB

May 20th 2021

Eravacycline Realizes Successful Clinical Endpoint in OPAT Facilities
Eravacycline Realizes Successful Clinical Endpoint in OPAT Facilities

June 11th 2020

CAMERA2: Standard MRSA Treatment Does Not Outperform Combination Therapy
CAMERA2: Standard MRSA Treatment Does Not Outperform Combination Therapy

February 19th 2020

Transitioning From Adequate to Optimal Therapy in Staphylococcus aureus Bacteremia

February 14th 2020

Video Series
Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.